title: Should red cell transfusions be leukoreduced in critically ill patients?
authors.forename: Douglas B
authors.initials: DB
authors.lastname: Coursin
authors.forename: Lisa E
authors.initials: LE
authors.lastname: Connery
authors.forename: John
authors.initials: J
authors.lastname: Weiss
mesh_terms: D016638:Critical Illness; D017707:Erythrocyte Transfusion / Q000009:adverse effects*; D006801:Humans; D007937:Leukapheresis; D007964:Leukocytosis / Q000517:prevention & control